Cargando…

Idiopathic hypereosinophilic syndrome with eosinophilic cellulitis-like cutaneous involvement treated with mepolizumab and dapsone

Detalles Bibliográficos
Autores principales:	Lachance, Madeleine, Bernard, Jean, Lavoie, Aubert, Gagné, Éric, Grenier, Pierre-Olivier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899130/ https://www.ncbi.nlm.nih.gov/pubmed/35265739 http://dx.doi.org/10.1016/j.jdcr.2022.01.022

Ejemplares similares

Dysphonia and dyspnea in idiopathic hypereosinophilic syndrome treated with Mepolizumab
por: Kay, Dana, et al.
Publicado: (2018)

Eosinophilic cellulitis (Wells syndrome) successfully treated with mepolizumab
por: Herout, Sandra, et al.
Publicado: (2018)

Idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab
por: Fujii, Koki, et al.
Publicado: (2020)

Mepolizumab in Hypereosinophilic Syndrome: A Systematic Review and Meta-analysis
por: Alves, José Mario, et al.
Publicado: (2021)

Characterization of disease flares and impact of mepolizumab in patients with hypereosinophilic syndrome
por: Pane, Fabrizio, et al.
Publicado: (2022)

Response to a case report: Idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab
por: Requena, Gema, et al.
Publicado: (2021)

Case Report: Mepolizumab in the treatment of idiopathic chronic eosinophilic pneumonia
por: Daboussi, Selsabil, et al.
Publicado: (2023)

Mepolizumab therapy improves the most bothersome symptoms in patients with hypereosinophilic syndrome
por: Roufosse, Florence, et al.
Publicado: (2023)

Idiopathic hypereosinophilic syndrome with cutaneous necrosis and multiorgan embolism
por: Wang, Huan, et al.
Publicado: (2019)

Mepolizumab: an alternative therapy for idiopathic chronic eosinophilic pneumonia with glucocorticoid intolerance
por: Kisling, Adam, et al.
Publicado: (2020)

Reply to Correspondence: Response to a case report: idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab
por: Fujii, Koki, et al.
Publicado: (2021)

Eosinophilic myocarditis and hypereosinophilic syndrome
por: Boussir, Hanane, et al.
Publicado: (2017)

Hypereosinophilic Syndrome With Eosinophilic Gastritis
por: Nayak, Vignesh Hebri, et al.
Publicado: (2017)

HYPEREOSINOPHILIC SYNDROME: CUTANEOUS INVOLVEMENT AS THE SOLE MANIFESTATION
por: Sundaramurthi, Vidya lakshmi, et al.
Publicado: (2011)

Idiopathic Hypereosinophilic Syndrome with Multiple Organ Involvement
por: Abo Shdid, Reham, et al.
Publicado: (2021)

Association Between Baseline Therapy and Flare Reduction in Mepolizumab-Treated Patients With Hypereosinophilic Syndrome
por: Reiter, Andreas, et al.
Publicado: (2022)

Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome
Publicado: (1989)

Idiopathic Hypereosinophilic Syndrome With Cutaneous Manifestations and Flame Figures: A Spectrum of Eosinophilic Dermatoses Whose Features Overlap With Wells' Syndrome
por: Smith, Sabrina M., et al.
Publicado: (2015)

Concurrent Use of Mepolizumab and Rituximab for Eosinophilic Granulomatosis With Polyangiitis and Multisystem Involvement
por: Afiari, Agura, et al.
Publicado: (2020)

Case of hypereosinophilic syndrome with gastrointestinal involvement showing tissue eosinophil cytolysis
por: Hagiwara, Shin-ichiro, et al.
Publicado: (2022)

Vesiculobullous eosinophilic annular erythema: A case report
por: Lachance, Madeleine, et al.
Publicado: (2023)

Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial
por: Roufosse, Florence, et al.
Publicado: (2020)

Blood Eosinophil Depletion with Mepolizumab, Benralizumab, and Prednisolone in Eosinophilic Asthma
por: Moran, Angela M., et al.
Publicado: (2020)

Clinical usefulness of mepolizumab in severe eosinophilic asthma
por: Menzella, Francesco, et al.
Publicado: (2016)

A Hypereosinophilic Syndrome Presenting as Eosinophilic Colitis
por: Jeon, Young Woo, et al.
Publicado: (2012)

Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseases
por: Menzella, Francesco, et al.
Publicado: (2015)

Eosinophil‐derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma
por: Howarth, Peter, et al.
Publicado: (2020)

Safety and Efficacy of Mepolizumab in Patients with Eosinophilic Granulomatosis with Polyangiitis
por: Pradhan, Ravi Ranjan, et al.
Publicado: (2019)

Precision medicine in COPD: review of mepolizumab for eosinophilic COPD
por: Long, Gabriella, et al.
Publicado: (2018)

Mepolizumab in the treatment of eosinophilic chronic obstructive pulmonary disease
por: Mkorombindo, Takudzwa, et al.
Publicado: (2019)

Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
por: Yancey, Steven W., et al.
Publicado: (2019)

Effectiveness of mepolizumab for eosinophilic pneumonia following bronchial thermoplasty
por: Otoshi, Ryota, et al.
Publicado: (2019)

Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO
por: Pavord, Ian D, et al.
Publicado: (2021)

Profile of Anti-IL-5 mAb Mepolizumab in the Treatment of Severe Refractory Asthma and Hypereosinophilic Diseases [Corrigendum]
Publicado: (2021)

Organ-Specific Hypereosinophilic Syndrome Presenting as Eosinophilic Gastroenteritis
por: Kumar, Aneesh, et al.
Publicado: (2021)

Eosinophilic myocarditis mimicking acute coronary syndrome secondary to idiopathic hypereosinophilic syndrome: a case report
por: Amini, Reza, et al.
Publicado: (2010)

Idiopathic hypereosinophilic syndrome with pulmonary hypertension
por: Zhang, Liping, et al.
Publicado: (2018)

Idiopathic hypereosinophilic syndrome presenting with liver mass: Report of two cases: Idiopathic hypereosinophilic syndrome and liver mass
por: shatery, Kamran, et al.
Publicado: (2011)

Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic syndrome in two patients with solid malignancies
por: Lazzari, Chiara, et al.
Publicado: (2023)

Patient profiles and clinical utility of mepolizumab in severe eosinophilic asthma
por: Haldar, Pranabashis
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sth749s6sc6b3t2cviu9vb09ba